Intrexon to deploy Novici's GRAMMR technology in concert with UltraVector platform

Intrexon Corporation, a next generation synthetic biology company, today announced an agreement with Novici Biotech LLC in which Intrexon has licensed certain non-exclusive rights to the use of Novici's patented GRAMMR^® technology for high-resolution genetic reassortment ("gene shuffling").

“Gene shuffling has been one of the cornerstone genetic technologies for optimization of industrial biomolecules”

According to Grace Colón, PhD, President of Intrexon's Industrial Products Division, Intrexon will be deploying Novici's GRAMMR^® technology toward a spectrum of industrial applications in concert with Intrexon's UltraVector^® platform and extensive library of modular DNA control components. "Gene shuffling has been one of the cornerstone genetic technologies for optimization of industrial biomolecules," states Colón. "The coordinated deployment of Novici's GRAMMR^® technology with our core UltraVector platform enables Intrexon to amplify the power of gene shuffling by incorporating optimized genes into our integrated genetic circuits and cellular control frameworks. The two platforms are an excellent complement and we look forward to maximizing the apparent synergies to derive high value industrial products."

"We are very pleased that Intrexon has chosen GRAMMR^® as a key upstream technology for use in its industrial products development," states Hal Padgett, PhD, Novici's General Manager and Chief Science Officer. "Intrexon's industrialization of complex transgene assembly, coupled with a superior ability to control cellular machinery, should produce many novel industrial applications and substantial improvements to existing ones. We look forward to enabling their use of GRAMMR^® and expect a very productive relationship."

The GRAMMR^® licensing agreement is part of Intrexon's ongoing strategic deployment of top-tier third party technologies in combination with the company's industry-shaping synthetic biology capabilities. Terms of the agreement were not made public.